| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |